Incyte to Report Third Quarter Financial Results

Rhea-AI Summary

Incyte (Nasdaq:INCY) has announced the schedule for its third quarter financial results conference call and webcast. The event is set for October 29, 2024, with the following timeline:

• Q3 2024 Press Release: 7:00 a.m. ET
• Q3 2024 Conference Call: 8:00 a.m. ET

Participants can join via phone using the provided domestic and international dial-in numbers, or access the live webcast with slides at Investor.Incyte.com. A replay of the call will be available for thirty days, and the webcast will be accessible for ninety days.

WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte (Nasdaq:INCY) announced today that it has scheduled its third quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, October 29, 2024.

The schedule for the press release and conference call/webcast is as follows:

• Q3 2024 Press Release:	October 29, 2024 at 7:00 a.m. ET
• Q3 2024 Conference Call:	October 29, 2024 at 8:00 a.m. ET
• Domestic Dial-In Number:	877-407-3042
• International Dial-In Number:	201-389-0864
• Conference ID Number:	13749146

If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13749146.

The live webcast with slides can be accessed at Investor.Incyte.com and will be available for replay for ninety days.

About Incyte

A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs. Through the discovery, development and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology and Inflammation & Autoimmunity. Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia.

For additional information on Incyte, please visit Incyte.com or follow us on social media: LinkedIn, X, Instagram, Facebook, YouTube.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241008194305/en/

Media

media@incyte.com

Investors

ir@incyte.com

Source: Incyte

FAQ

When will Incyte (INCY) report its Q3 2024 financial results?

Incyte (INCY) will report its Q3 2024 financial results on October 29, 2024. The press release will be issued at 7:00 a.m. ET, followed by a conference call and webcast at 8:00 a.m. ET.

How can investors access Incyte's (INCY) Q3 2024 earnings call?

Investors can access Incyte's (INCY) Q3 2024 earnings call by dialing 877-407-3042 (U.S.) or 201-389-0864 (International), using the conference ID 13749146. Alternatively, a live webcast will be available at Investor.Incyte.com.

Will there be a replay available for Incyte's (INCY) Q3 2024 earnings call?

Yes, a replay of Incyte's (INCY) Q3 2024 earnings call will be available for thirty days. The U.S. replay dial-in number is 877-660-6853, and for international callers, it's 201-612-7415, using the conference ID 13749146.

How long will Incyte's (INCY) Q3 2024 earnings webcast be available for replay?

Incyte's (INCY) Q3 2024 earnings webcast will be available for replay on Investor.Incyte.com for ninety days following the live event on October 29, 2024.